Extrauterine Intrapartum Treatment (EXIT) in bilateral primary fetal hydrothorax.

Indian J Pediatr

Department of Pediatric Surgery, SAT Hospital, Medical College, Thiruvananthapuram Dr. SMCSI Medical College, Karakkoram, Thiruvananthapuram, Kerala, India.

Published: January 2009

Primary Foetal Hydrothorax (PFHT), is an intrathoracic collection of fluid in the fetus, which may be present on either side or even bilaterally. Advances in foetal diagnostics now allow consideration of the Ex-utero Intrapartum Treatment (EXIT) procedure for PFHT. Ex-utero Intrapartum Treatment (EXIT) allows therapeutic interventions on the neonate while maintaining fetoplacental circulation and thereby maintaining oxygenation. We report two cases of bilateral PFHT managed successfully with EXIT procedure.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12098-009-0038-9DOI Listing

Publication Analysis

Top Keywords

intrapartum treatment
12
treatment exit
12
ex-utero intrapartum
8
exit procedure
8
extrauterine intrapartum
4
exit
4
exit bilateral
4
bilateral primary
4
primary fetal
4
fetal hydrothorax
4

Similar Publications

A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.

Neurol Clin Pract

April 2025

Brigham MS Center (MKH), Harvard Medical School, Boston, MA; Georgia State University (MCM), Atlanta; Brigham and Women's Hospital (TDM, JP-P, CS, JZ), Boston, MA; Massachusetts General Hospital (ECK), Harvard Medical School, Boston, MA; University of Vermont (AJS), Burlington; Elliot Lewis MS Center (EL, JK), Wellesley, MA; University of Massachusetts (CI, IB), Worcester, MA; Novartis Pharmaceuticals (JMS), Jersey City, NJ; Concord Hospital (AC), NH; and University of British Columbia (ADS), Vancouver, BC, Canada.

Background And Objectives: Multiple sclerosis (MS) affects more than 1 million people in the United States, including reproductive-age women. There has been a paucity of prospective, pregnancy registries based on MS disease rather than medication exposures. A prospective MS pregnancy registry (PREG-MS) was established in 2017 as a prospective, single-cohort, real-world MS pregnancy registry in New England States of the United States, with goals to evaluate (1) course of MS and disease-modifying therapies (DMT) use during conception attempts and in the peripartum period, (2) pregnancy outcomes in women with MS (WwMS), and (3) longer-term developmental outcomes in offspring of WwMS.

View Article and Find Full Text PDF

Amniotic fluid assessment is crucial in prenatal ultrasound to monitor fetal conditions, with polyhydramnios, characterized by excessive amniotic fluid, affecting 1%-2% of pregnancies. Polyhydramnios is linked to complications such as placental abruption, preterm labor, congenital anomalies, and postpartum hemorrhage, emphasizing the need for early detection and management. While idiopathic causes account for 60%-70% of cases, other causes include impaired fetal swallowing and increased urine production due to maternal, fetal, and placental conditions.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the prenatal and perinatal outcomes of pregnancies affected by inherited metabolic disorders (IMDs), identifying common issues like intrauterine growth restriction (IUGR), microcephaly, and oligohydramnios.
  • Mitochondrial disorders were linked to higher rates of oligohydramnios, IUGR, microcephaly, and heart problems, significantly impacting obstetric outcomes.
  • Early identification of risk factors and complications in these pregnancies can lead to better interventions and improved health for both mothers and infants.
View Article and Find Full Text PDF

Background: Epignathus is a rare kind of teratoma. Its estimated incidence is one in 35,000-200,000 live births, and it may cause high mortality by causing airway obstruction in the neonatal period. It is generally diagnosed in the prenatal period.

View Article and Find Full Text PDF
Article Synopsis
  • Group B streptococcus (GBS) is a significant cause of infections in neonates and pregnant women, with Japan implementing guidelines for screening and antibiotic use, yet infections have not decreased significantly.
  • Approximately 15% of pregnant women lack GBS screening, and issues like intermittent colonization lead to early-onset disease; current preventative measures don't address increasing cases of late-onset disease.
  • This study found that using polymerase chain reaction for GBS detection was more effective than culture methods, highlighted the risk of horizontal transmission, and emphasized the need for better diagnostic tools and potential maternal vaccination for prevention.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!